Literature DB >> 22327903

Methodological weaknesses in non-randomized studies of ecstasy (MDMA) use: a cautionary note to readers and reviewers.

Teri S Krebs, Pål-Ørjan Johansen.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22327903      PMCID： PMC3280641          DOI： 10.1038/npp.2011.202

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  Impulsivity and BOLD fMRI activation in MDMA users and healthy control subjects.

Authors:  Ignacio H Valdes; Joel L Steinberg; Ponnada A Narayana; Larry A Kramer; Donald M Dougherty; Alan C Swann; Ernest S Barratt; Frederick Gerard Moeller
Journal:  Psychiatry Res       Date:  2006-08-04       Impact factor: 3.222

2.  Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.

Authors:  T S Krebs; P-Ø Johansen; L Jerome; J H Halpern
Journal:  Psychol Med       Date:  2009-02-12       Impact factor: 7.723

3.  Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.

Authors:  Ralph Buchert; Rainer Thomasius; Kay Petersen; Florian Wilke; Jost Obrocki; Bruno Nebeling; Lutz Wartberg; Pavlina Zapletalova; Malte Clausen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-17       Impact factor: 9.236

4.  Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Authors:  Amy L Bauernfeind; Mary S Dietrich; Jennifer U Blackford; Evonne J Charboneau; James G Lillevig; Christopher J Cannistraci; Neil D Woodward; Aize Cao; Tristan Watkins; Christina R Di Iorio; Carissa Cascio; Ronald M Salomon; Ronald L Cowan
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

5.  An auditory fMRI correlate of impulsivity.

Authors:  Markus Röhl; Stefan Uppenkamp
Journal:  Psychiatry Res       Date:  2010-01-18       Impact factor: 3.222

6.  Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.

Authors:  Maartje M L de Win; Gerry Jager; Jan Booij; Liesbeth Reneman; Thelma Schilt; Cristina Lavini; Sílvia D Olabarriaga; Gerard J den Heeten; Wim van den Brink
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501
  6 in total
  2 in total

Review 1.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

2.  Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.

Authors:  Sascha B Thal; Miriam J J Lommen
Journal:  J Contemp Psychother       Date:  2018-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.